Erectile dysfunction, lower urinary tract symptoms, and quality of life in men above 50 years of age
- PMID: 33650537
Erectile dysfunction, lower urinary tract symptoms, and quality of life in men above 50 years of age
Abstract
Background: Lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) are relevant health problems worldwide, especially in men 50 years of age and older. With the increase in life expectancy, their prevalence is expected to rise in the coming years.
Aim: To estimate the prevalence of LUTS and ED in adults 50 years of age and older and evaluate their relation to quality of life.
Materials and methods: An analytic cross-section-al study was conducted through a personal interview with the participants. Erectile dysfunction (IIEF-5), prostate symptom (IPSS), and quality of life (EuroQoL) questionnaires were employed. The frequency and grade of LUTS and ED were evaluated and correlated with health-related quality of life perception in 300 men above 50 years of age. Summary measures were calculated. The association of LUTS and ED with quality of life was evaluated with prevalence odds ratios (ORs) and 95% confidence intervals (CIs), calculated using unconditional logistic regression models.
Results: Information on 300 subjects was analyzed. The general prevalence of LUTS and ED was 88.3% and 81.7%, respectively. Quality of life was classified as very poor - regular (≤ 60 points) in 18.3% of the subjects. In the multiple analysis, the presence of moderate LUTS (OR = 5.27, 1.08 - 9.73) or severe LUTS (OR = 7.05, 1.84-10.34) was associated with an increase in the possibility of presenting with a lower quality of life.
Conclusion: Our findings suggest that erectile dysfunction and prostate symptoms were frequent events in the population studied, as was a low perception of quality of life. The opportune and efficacious treatment of those pathologies can potentially improve the individual and social dynamics of the persons affected.
Antecedentes: A nivel mundial, los Síntomas del Tracto Urinario Inferior (STUI) y la Disfunción Eréctil (DE) son un problema relevante de salud pública, especialmente en varones de 50 o más años. Se espera que con el aumento de la esperanza de vida, su prevalencia se incrementa aún más en los próximos años.
Objetivo: Estimar la prevalencia de los STUI y DE en adultos de 50 años o más de edad y evaluar su relación con la calidad de vida.MATERIAL Y MÉTODOS: Se realizó un estudio transversal analítico a través de una entrevista personal con los participantes. Se emplearon los cuestionarios de disfunción eréctil (IIEF-5), de síntomas prostáticos (IPSS) y la calidad de vida (EuroQoL). Se evaluó la frecuencia y grados de los Síntomas del Tracto Urinario Inferior y Disfunción Eréctil y se correlacionó con la percepción de Calidad de Vida relacionada a la salud en 300 varones mayores de 50 años. Se estimaron medidas sumarias. La asociación de STUI y DE con la calidad de vida fue evaluada con razones de momios (RM) prevalentes e intervalos de confianza (IC) del 95% estimados con modelos de regresión logística no condicional.
Resultados: Información de 300 sujetos fue analizada. La prevalencia general de STUI y DE fue 88,3% y 81,7% respectivamente. El 18,3% de los sujetos fueron clasificados como con una calidad de vida muy mala – regular (≤ 60 puntos). En el análisis múltiple, la presencia de STUI moderados (RM = 5,27, 1,08 – 9,73) o severos (RM = 7,05, 1,84 -10,34) se asoció con un incremento en la posibilidad de presentar una menor calidad de vida.CONCLUSIÓN: Nuestros hallazgos sugieren que la disfunción eréctil y los síntomas prostáticos son eventos frecuentes en la población estudiada, al igual que una baja percepción de la calidad de vida. La atención oportuna y eficaz de estas patologías puede potencialmente mejorar la dinámica individual y social de los sujetos afectados.
Keywords: Benign Prostatic Hyperplasia; Calidad de Vida; Disfunción Eréctil; Erectile dysfunction; Hiperplasia Benigna Prostática; LUTS; Prevalence; Prevalencia; Quality of Life; STUI; Urology; Urología.
Similar articles
-
Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.Med Arch. 2017 Feb;71(1):32-36. doi: 10.5455/medarh.2017.71.32-36. Epub 2017 Feb 5. Med Arch. 2017. PMID: 28428671 Free PMC article.
-
Is It Compulsory to Investigate for Erectile Dysfunction in Patients Presenting for Low Urinary Tract Symptoms?Eur Urol Focus. 2021 Jan;7(1):172-177. doi: 10.1016/j.euf.2019.08.007. Epub 2019 Aug 30. Eur Urol Focus. 2021. PMID: 31474582
-
Assessment of Female Sexual Dysfunction and Erectile Dysfunction and Its Association with Lower Urinary Tract Symptoms in Women and Men Over 18 Years Old: Results From the COBaLT Study.J Sex Med. 2021 Jun;18(6):1065-1074. doi: 10.1016/j.jsxm.2021.02.009. Epub 2021 May 13. J Sex Med. 2021. PMID: 33992556
-
Erectile Dysfunction and Lower Urinary Tract Symptoms.Eur Urol Focus. 2017 Oct;3(4-5):352-363. doi: 10.1016/j.euf.2017.11.004. Epub 2017 Nov 27. Eur Urol Focus. 2017. PMID: 29191671 Review.
-
[Relationship between lower urinary tract symptoms in men and erectile dysfunction].Semergen. 2016 Apr;42(3):164-71. doi: 10.1016/j.semerg.2015.07.005. Epub 2015 Dec 10. Semergen. 2016. PMID: 26452608 Review. Spanish.
Cited by
-
Association between erectile dysfunction and Helicobacter pylori, folic acid, vitamin B12, and homocysteine: a cross-sectional study.Sex Med. 2023 Mar 1;11(2):qfac018. doi: 10.1093/sexmed/qfac018. eCollection 2023 Apr. Sex Med. 2023. PMID: 36910702 Free PMC article.
-
Sildenafil effect on testosterone-induced prostate hypertrophy and relaxation of urinary bladder neck muscles.Toxicol Rep. 2025 Jun 30;15:102080. doi: 10.1016/j.toxrep.2025.102080. eCollection 2025 Dec. Toxicol Rep. 2025. PMID: 40678732 Free PMC article.
-
Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms.Int Urol Nephrol. 2022 Sep;54(9):2157-2165. doi: 10.1007/s11255-022-03294-2. Epub 2022 Jul 8. Int Urol Nephrol. 2022. PMID: 35804206
-
Predicting Anxiety and Depression Among Erectile Dysfunction Patients: A Cross-Sectional Study.Am J Mens Health. 2024 Jan-Feb;18(1):15579883231223502. doi: 10.1177/15579883231223502. Am J Mens Health. 2024. PMID: 38288597 Free PMC article.
-
QSAR, molecular docking, MD simulations, and ADMET screening identify potential Heliotropium indicum leads against key targets in benign prostatic hyperplasia.In Silico Pharmacol. 2024 Nov 19;12(2):107. doi: 10.1007/s40203-024-00280-7. eCollection 2024. In Silico Pharmacol. 2024. PMID: 39569034
MeSH terms
LinkOut - more resources
Full Text Sources
Medical